Dialogue on DD treatment measures — complexity as a road to meaningful simplicity

Barrowclough C. , & Haddock G. , & Tarrier N. , & Lewis S. W. , & Moring J. , & O'Brien R. , & Schofield N. , & McGovern J. (2001): Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry 158(10): 1706–1713

Cleary M. , & Hunt G. E. , & Matheson S. , & Siegfried N. & Walter G. (2008): Psychosocial Treatment Programs for People with both Severe Mental Illness and Substance Misuse. Schizophrenia Bulletin 34(2): 226–228

Drake R. E. , & Mercer-McFadden C. , & Mueser K. T. , & McHugo G. J. , & Bond G.R. (1998) Treatment of substance abuse in patients with severe mental illness: A review of recent research. Schizophrenia Bulletin 24 (4): 589–608

Jourdan M. (2009): Casting light on harm reduction. Introducing two instruments for analyzing contradictions between harm reduction and ‘non-harm reduction’. International Journal of Drug Policy, In press.

Jöhncke S. (2008): Treatment trouble. On the politics of methadone and anthropology. København: Department of Anthropology, ph.d.

Minkoff K. (2001). Developing standards of care for individuals with co-occurring psychiatric and substance use disorders. Psychiatric Services 52 (5): 597–599.